Our vision for this synthesizer technology is to support the scientific community and lower the barriers to their work, so you can do what you do best—better the human condition through science.
Scientists are constrained by resources, time, and money. These constraints impede medical, social and economic progress. What could have been the next big breakthrough for cancer treatment might be canceled because of budgets, bandwidth, or bureaucracy. At Eurofins Genomics, we believe that lowering the barriers between researchers and their work leads to more frequent breakthroughs that will change the world.
Unlike other “next generation” technologies, the quality on our oligos is outstanding.
Fastest Oligos in the World
Our vision for the finished product is to provide the fastest turnaround time in the industry.
This lower scale platform provides cost advantages that we can pass along to our customers.
Everyone claims to have built the next generation synthesis technology, but many fall below expectations due to low quality or downstream issues. Eurofins Genomics successfully engineered a next-generation DNA synthesizer that produces high quality, lower yield oligos in a shorter time. Also due to the incredible power and speed of the machine, it raises the ceiling on scalability and volume.
At Eurofins Genomics, we believe in proven science, not big promises. While other companies courted investor and media attention, we kept quiet and focused on the science. After years of diligent, hard work, we are proud of this new synthesis technology. We believe it will usher in a new era of research and scientific progress. We believe our oligos are better, but we want you to try them. Click here to request access.
Scalability to Large Volumes
The capacity for this technology is almost limitless, providing your greater flexibility to increase volume.
High-fidelity, low-yield oligos that are prefect for any PCR based application.
This new echelon of oligonucleotides are optimized for a variety of applications such as Genes, CRISPRs, and more.
This Beta Test is an experiment, which all scientists must appreciate. The goal is to learn how these oligos perform in functional applications and gather data. We may make adjustments to the new synthesis technology during testing, based on feedback and data. Please note that the Beta oligos are not a true representation of the final product. They are a prototype of the final product.
We will accept a small number of special customers into the Beta Test. These testers will gain exclusive access to the new product and price. To request access to the beta, please send an email explaining your project and what you wish to accomplish with it. Also, please include the scope and scale of the project along with any special restrictions on the project, such as turnaround time, special sequences, special delivery needs, and more. Beta testing is currently open.
All requests will be approved or rejected based on the project’s parameters, the impact, and our best judgement.
After submitting the order, you will receive a request for feedback on how the oligos performed in your experiment. Furthermore, this information may be used later in a citation, white paper, or other marketing material if the user approves. Sharing information publicly is optional, not required. However, we hope that Beta testers will support the project moving forward.
Turnaround time will vary based on order size and the number of beta users.